Birgit Wehnl

Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China

Catharina M. Korse, Stefan Holdenrieder, Xiuyi Zhi et al. · Clinica Chimica Acta · 2014 · 40 citations · Full text

Pharmacy, Oncology, Cancer Prevention +14

Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung

Thomas Muley, Ying He, Vinzent Rolny et al. · Lung Cancer · 2019 · 27 citations · Full text

Medicine, Oncology, Pathology +17

The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)

Thomas Muley, Vinzent Rolny, Ying He et al. · Lung Cancer · 2018 · 24 citations · Full text

Medicine, Oncology, Chemotherapy +14

Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission

Thomas Muley, Felix Herth, Claus Peter Heußel et al. · Tumor Biology · 2023 · 14 citations · Full text

Medicine, Oncology, Chemotherapy +14